Background It has been suggested that p53 plays an important part in g
astric carcinogenesis but the data remain inconclusive. Methods Altera
tion of the tumour suppressor gene p53 was prospectively investigated
by immunohistochemistry in 168 primary gastric cancers. Results Positi
ve staining? indicative of gene mutations, was detected in 34 tumours
(20.2 per cent). No correlation was observed between expression of p53
and various clinicopathological factors, including age, sex, tumour s
ite, gross type, tumour size, depth of invasion, lymph node metastases
, distant metastases, and tumour node metastasis stage. However, p53 o
verexpression was different between intestinal and diffuse type gastri
c cancer. Survival analysis revealed a significant survival disadvanta
ge of p53 expression in diffuse type gastric cancer (P = 0.039) but no
t in the intestinal type. Multivariate analysis of all 168 patients re
vealed that independent predictors of recurrent disease included age,
invasion depth and nodal involvement but not p53 expression. Conclusio
n The presence of p53 overexpression may identify a subset of more agg
ressive tumours with a poor prognosis in diffuse type gastric cancer.